LeMaitre Vascular Q1 2024 GAAP EPS $0.44 Beats $0.38 Estimate, Sales $53.478M Beat $51.506M Estimate
Portfolio Pulse from Benzinga Newsdesk
LeMaitre Vascular (NASDAQ:LMAT) reported Q1 2024 earnings of $0.44 per share, surpassing the $0.38 estimate, a 62.96% increase from last year. Sales reached $53.478M, beating the $51.506M estimate, marking a 13.60% increase from the previous year.
May 02, 2024 | 9:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
LeMaitre Vascular reported a significant beat on both earnings per share and sales for Q1 2024, with earnings per share at $0.44 against a $0.38 estimate and sales at $53.478M against a $51.506M estimate.
LeMaitre Vascular's earnings and sales beat are significant indicators of the company's strong performance and growth, likely leading to positive investor sentiment and a potential increase in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100